William Blair Investment Management LLC Invests $785,000 in Cencora, Inc. $COR

William Blair Investment Management LLC bought a new stake in Cencora, Inc. (NYSE:COR) during the second quarter, according to its most recent filing with the SEC. The firm bought 2,775 shares of the company’s stock, valued at approximately $785,000.

Other institutional investors have also recently bought and sold shares of the company. Kemnay Advisory Services Inc. acquired a new stake in shares of Cencora in the fourth quarter valued at about $25,000. Oakworth Capital Inc. acquired a new position in shares of Cencora during the 4th quarter worth about $26,000. Elyxium Wealth LLC bought a new stake in Cencora during the 4th quarter valued at approximately $27,000. Elevation Wealth Partners LLC boosted its stake in Cencora by 506.2% during the 2nd quarter. Elevation Wealth Partners LLC now owns 97 shares of the company’s stock valued at $27,000 after purchasing an additional 81 shares during the period. Finally, Archer Investment Corp grew its holdings in Cencora by 134.3% in the 4th quarter. Archer Investment Corp now owns 82 shares of the company’s stock valued at $28,000 after buying an additional 47 shares during the last quarter. Institutional investors own 97.52% of the company’s stock.

Insider Transactions at Cencora

In other Cencora news, Director Lauren M. Tyler acquired 550 shares of the company’s stock in a transaction dated Monday, June 22nd. The stock was bought at an average price of $270.23 per share, for a total transaction of $148,626.50. Following the purchase, the director owned 4,359 shares in the company, valued at $1,177,932.57. This represents a 14.44% increase in their position. The transaction was disclosed in a filing with the SEC, which is available through this link. 0.38% of the stock is owned by company insiders.

Cencora Price Performance

Shares of COR stock opened at $317.89 on Monday. The stock has a 50 day moving average of $302.59 and a two-hundred day moving average of $311.52. The company has a current ratio of 0.93, a quick ratio of 0.58 and a debt-to-equity ratio of 3.53. Cencora, Inc. has a 12 month low of $244.82 and a 12 month high of $377.54. The company has a market capitalization of $60.66 billion, a P/E ratio of 23.62, a P/E/G ratio of 1.83 and a beta of 0.57.

Cencora (NYSE:COR) last announced its quarterly earnings data on Wednesday, August 5th. The company reported $4.48 earnings per share for the quarter, topping the consensus estimate of $4.35 by $0.13. The company had revenue of $84.75 billion for the quarter, compared to analyst estimates of $84.31 billion. Cencora had a return on equity of 125.45% and a net margin of 0.79%.Cencora’s revenue for the quarter was up 5.1% compared to the same quarter last year. During the same quarter last year, the firm earned $4.00 EPS. As a group, equities analysts expect that Cencora, Inc. will post 17.87 EPS for the current year.

Cencora declared that its board has initiated a stock buyback program on Thursday, May 21st that allows the company to repurchase $2.00 billion in shares. This repurchase authorization allows the company to buy up to 3.9% of its shares through open market purchases. Shares repurchase programs are typically a sign that the company’s leadership believes its stock is undervalued.

Cencora Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Monday, August 31st. Shareholders of record on Friday, August 14th will be paid a dividend of $0.60 per share. The ex-dividend date is Friday, August 14th. This represents a $2.40 dividend on an annualized basis and a yield of 0.8%. Cencora’s payout ratio is currently 17.83%.

Wall Street Analyst Weigh In

A number of research analysts have recently commented on the company. William Blair began coverage on Cencora in a report on Tuesday, April 28th. They set a “market perform” rating for the company. Robert W. Baird set a $370.00 price objective on shares of Cencora in a research note on Thursday, August 6th. Barclays dropped their target price on shares of Cencora from $425.00 to $350.00 and set an “overweight” rating on the stock in a research report on Wednesday, June 10th. Evercore reiterated an “outperform” rating and set a $350.00 target price on shares of Cencora in a research note on Thursday, August 6th. Finally, Wells Fargo & Company raised their price target on shares of Cencora from $331.00 to $395.00 and gave the stock an “overweight” rating in a research report on Tuesday, August 11th. Thirteen equities research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company’s stock. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average target price of $370.85.

Cencora Company Profile

Cencora (NYSE:COR) is a global healthcare services and pharmaceutical distribution company that provides end-to-end solutions across the pharmaceutical supply chain. The company’s core activities include wholesale drug distribution, specialty drug distribution, and the operation of specialty pharmacies, complemented by logistics, cold-chain management and other fulfillment services designed to support complex and temperature-sensitive therapies.

Beyond physical distribution, Cencora offers a range of commercial and patient-focused services for pharmaceutical manufacturers and healthcare providers.